
    PAR PHARMACEUTICAL, INC., Alkermes Pharma Ireland Limited, Plaintiffs-Appellants v. TWI PHARMACEUTICALS, INC., Defendant-Appellee.
    No. 2015-1880.
    United States Court of Appeals, Federal Circuit.
    Dec. 15, 2015.
    Daniel Brown, Latham & Watkins LLP, New York, N.Y., argued for plaintiffs-appellants. Plaintiff-appellant Par Pharmaceutical, Inc., also represented by Roger J. Chin, Gregory Sobolski, San Francisco, CA; Jonathan Y. Ellis, Gregory G. Garre, Michael J. Gerardi, Washington, DC; James Patrick Ulwick, Kramon and Graham, P.A., Baltimore, MD.
    Maryellen Noreika, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE, for plaintiff-appellant Alkermes Pharma Ireland Limited. Also represented by Jack B. Blumenfeld, Jeremy A. Tigan; James Patrick Ulwick, Kramon and Graham, P.A., Baltimore, MD.
    Donald J. Mizerk, Husch Blackwell LLP, Chicago, IL, argued for defendant-appellee. Also represented by Philip Dale Segrest, Jr., John A. Sholar, Jr.
    O’MALLEY, PLAGER, and WALLACH, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.  